This result is consistent with multiple studies reporting that BTG2 plays an anti-proliferative role in breast cancer [52, 53], pancreatic cancer [54], and vertebral patterning by modulating bone morphogenesis [55], homeotic transformation of the axial skeleton [56, 57], and stress response [18]. The gene discussed is BTG2; the disease is familial pancreatic carcinoma.